You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Solid tumor malignancy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Peritoneal Metastases, Peritoneal Cancer Trial in Haifa, Jerusalem, Ramat Gan (Allocetra-OTS, nivolumab)

Recruiting
  • Solid Tumor
  • +2 more
  • Haifa, Israel
  • +2 more
Oct 12, 2022

Participants Previously Treated With Century Therapeutics

Not yet recruiting
  • Hematological Malignancy
  • Solid Tumor Malignancy
  • No Intervention
  • (no location specified)
Mar 3, 2023

Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)

Recruiting
  • Solid Tumor Malignancy
  • +4 more
  • mRNA-1273
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 14, 2023

Advanced Solid Tumor Malignancy Trial in Ghent (KBA1412, Pembrolizumab)

Recruiting
  • Advanced Solid Tumor Malignancy
  • Ghent, Belgium
    University Hospital Ghent
Aug 11, 2022

Prospective Procurement of Tumor Tissue to Identify Novel

Enrolling by invitation
  • Solid Tumors
  • +7 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Cancer, Solid Tumor Trial in San Francisco (Personalized Synthetic Long Peptide Vaccine)

    Enrolling by invitation
    • Cancer
    • Solid Tumor
    • Personalized Synthetic Long Peptide Vaccine
    • San Francisco, California
      Quest Clinical Research
    Feb 20, 2023

    Solid Tumor Malignancy Trial in Hackensack (Selinexor, Irinotecan)

    Withdrawn
    • Solid Tumor Malignancy
    • Hackensack, New Jersey
      John Theurer Cancer Center at HackensackUMC
    Dec 14, 2021

    COVID-19 Vaccines in Cancer, Transplant or Cellular Therapy

    Recruiting
    • Cancer
    • +7 more
      • Memphis, Tennessee
      • +2 more
      Mar 2, 2022

      Metastatic or Unresectable Solid Tumor Malignancy Trial in Fort Myers, Oklahoma City, Nashville (Capecitabine, Hsp90 Inhibitor

      Completed
      Has Results
      • Metastatic or Unresectable Solid Tumor Malignancy
      • Fort Myers, Florida
      • +2 more
      Feb 15, 2022

      Immune Profiling for Cancer Immunotherapy Response

      Recruiting
      • Cancer
      • +3 more
      • Methylation Cytometry
      • Lebanon, New Hampshire
        Dartmouth-Hitchcock Medical Center
      Nov 6, 2023

      Hematological Malignancy, Solid Tumor Trial (OT-A201, IMids, Bevacizumab)

      Not yet recruiting
      • Hematological Malignancy
      • Solid Tumor
      • (no location specified)
      Apr 24, 2023

      Solid Tumor, Hematological Malignancy Trial in Fairfax (Locus Health iPhone App)

      Not yet recruiting
      • Solid Tumor
      • Hematological Malignancy
      • Locus Health iPhone App
      • Fairfax, Virginia
        Inova Schar Cancer Institute
      Oct 24, 2023

      Immunity to Infection in Healthy Participants and Cancer

      Recruiting
      • Influenza
      • +3 more
      • Biological sample collection
      • Tuebingen, Baden-Wuerttemberg, Germany
        University Hopsital Tuebingen
      Mar 31, 2023

      Solid Tumor, Unspecified, Adult, Haematological Malignancy Trial in Aalborg

      Recruiting
      • Solid Tumor, Unspecified, Adult
      • Haematological Malignancy
        • Aalborg, Denmark
          Department of Oncology, Aalborg University Hospital
        Jan 20, 2023

        Solid Tumor, Hematologic Malignancy Trial in Beijing (Eliglustat, Immune checkpoint inhibitor)

        Recruiting
        • Solid Tumor
        • Hematologic Malignancy
        • Beijing, China
          Department of Biotherapeutic, Chinese PLA General Hospital
        Apr 28, 2022

        Molecular Services and EMR-Lab Integration Application for

        Not yet recruiting
        • Advanced Cancer
        • +2 more
        • Comprehensive Genomic Profile testing; ELIA software; Molecular Genetic Pathologist consultation
        • limited genetic testing or no testing
        • Rock Hill, South Carolina
          Carolina Blood and Cancer Care Associates
        Oct 18, 2023

        Hematologic Malignancy, Solid Tumor, Fibrosis Trial in Seoul (Ivaltinostat, Placebo)

        Not yet recruiting
        • Hematologic Malignancy
        • +2 more
        • Seoul, Korea, Republic of
          Seoul National University Hospital
        Feb 6, 2023

        Hematologic Malignancies Trial in Shanghai (GNC-035)

        Recruiting
        • Hematologic Malignancies
        • Guiyang, Guizhou, China
        • +3 more
        Jan 13, 2023

        Solid Tumor, Solid Carcinoma, Solid Tumor, Adult Trial in United States (Benralizumab)

        Recruiting
        • Solid Tumor
        • +3 more
        • Basking Ridge, New Jersey
        • +4 more
        Jan 18, 2023

        Solid Tumor, Hematological Malignancy Trial in Australia (ATG-017)

        Recruiting
        • Solid Tumor
        • Hematological Malignancy
        • East Melbourne, Victoria, Australia
        • +4 more
        Jan 11, 2023

        Technology to Assess Vulnerable Older Cancer and Their

        Active, not recruiting
        • Cancer
        • +2 more
          • Duarte, California
            City of Hope Medical Center
          Jan 4, 2023

          Cancer, Solid Tumor, Hematologic Malignancy Trial in Hangzhou (engineered red blood cell WTX212)

          Recruiting
          • Cancer
          • +2 more
          • engineered red blood cell WTX212
          • Hangzhou, Zhejiang, China
            Zhejiang Provincial People'S Hospital
          Jan 21, 2023

          Solid Tumor, Carcinoma, Malignancy Trial in Hong Kong (propofol, sevoflurane)

          Recruiting
          • Solid Tumor
          • +3 more
          • Hong Kong, Hong Kong
            Hong Kong Children's Hospital
          Mar 14, 2022

          Central Venous Catheter-related Complications in Patients Under

          Not yet recruiting
          • Central Venous Catheter Thrombosis
          • +3 more
          • central venous catheter
          • (no location specified)
          Jul 8, 2022

          Melanoma (Skin), Solid Tumor Trial in Australia, United States (PI-88)

          Completed
          • Melanoma (Skin)
          • Unspecified Adult Solid Tumor, Protocol Specific
          • Aurora, Colorado
          • +4 more
          Jun 21, 2022